Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology
The European Group on Ethics in Science and New Technologies (EGE), an independent advisory body to the Commission, has today published its Opinion on the ethics of genome editing. The Opinion analyses ethical questions raised by the application of genome editing in humans, animals and plants, and hence spans health, research, agriculture and environmental aspects.
The pandemic has given scientists a more prominent voice in society. They need to use it to push for better health through equality.
MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space. The pneumatically driven syringe system allows the surgeon to utilize a pneumatic air source, such as a vitrectomy system, to deliver a low volume injection into the subretinal space.
The importance of publications won’t come as news to anyone who has been in academia for a while. Still, Rolfs’s comments underscore the importance of not just doing good science, but also ensuring you receive appropriate recognition for it—particularly when it comes to authorship.
Over the years, new scientific discoveries have led to softer and more comfortable contact lenses. And now, research bringing together chemistry, biology and microelectronics is resulting in contact lenses that are straight out of science fiction.
The Children’s Eye Foundation of AAPOS unveiled the world’s first interactive children’s book to help screen for color vision deficiency (CVD), commonly known as color blindness. The foundation has posted a free digital version of THE CURIOUS EYE at thecuriouseye.org and published a first-run, hardcover book for its member pediatric ophthalmologists.
Commissioner Gabriel appointed two new members to the European Commission’s Group of Chief Scientific Advisors (GCSA) for the next three years.
Oxford Finance has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals. Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the company’s marketing of its two approved ophthalmic products.
The importance of knowledge creation and research for our well-being and the prosperity of our society and economies cannot be overstated. The ability to formulate questions and to seek answers to understand the world around us is a distinguishing feature of being human.
Nanoscope Technologies LLC, a biotechnology company developing gene therapies for treatment of retinal diseases, is featuring multiple scientific presentations highlighting its groundbreaking research on optical gene delivery for vision restoration and OCT-guided electrophysiology platforms for characterization of retinal degeneration and assessment of efficacy of cell-gene therapy at the 2021 ARVO annual meeting
Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties.
Last year, the COVID-19 pandemic upended the conference experience for researchers around the globe as scientific societies canceled in-person meetings and scrambled to hold virtual events in their place—with varying success.
It's critical for parents to maintain their children's vision checkups during the COVID-19 pandemic, an expert says.
Bausch + Lomb, announced that the FDA has approved ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.